News

BÜHLMANN Laboratories AG is proud to celebrate its 40 Years Anniversary in 2016. A public symposium with the topic “Aging and Biology” will be held on Friday, 8th of April 2016 in honor to the long-lasting and unique success story in developing, manufacturing and selling of diagnostic products. Read more…

Join BÜHLMANN Laboratories AG and BUHLMANN Diagnostics Corp (BDC) Tuesday April 19, 2016 11:00AM EST/ 8:00AM PST/ 5:00PM CET Inhibitors of PI3K and BTK pathways are a large focus for pharmaceutical companies with several small molecule inhibitors currently at different stages of development. Enzymatic assays to measure the direct activity of compounds are available in

We are proud to announce the launch of the new Quantum Blue® Infliximab trough level rapid test. Detection and monitoring of serum levels of the anti-TNFalpha monoclonal antibody is a key element in the treatment of IBD patients and helps to manage dosage of the infliximab therapy. Read more.

We are proud to announce that our new affiliate, BUHLMANN Diagnostics Corporation (BDC), based in Amherst, NH, USA now directly serves our customers in the USA and Canada. “We are excited about the opportunity to work directly with our customers, BDC will help us foster closer relationships and enhance our customer support interactions as well